A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer recurrence by approximately 55% in patients with specific PI3K pathway mutations.

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

A new study has revealed that a common over-the-counter medication, aspirin, can cut the risk of colorectal cancer recurrence ...

A clinical trial called ALASCCA, which has been published in The New England Journal of Medicine, shows that patients with ...

Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase 3 ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study ...

PI3K Pathway Aberrations May Reveal Targeted Therapy Opportunities Combination therapies targeting both mutations in the PI3K pathway and HER2 or hormone receptor overexpression should be evaluated, ...

Hypertrophic cardiomyopathy (HCM) is an inherited disease characterized by diastolic dysfunction, fibrosis, and asymmetric ...

Liver fibrosis, a pathological scarring process resulting from chronic liver injury, represents a significant global health ...

Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for approximately 90% of ...